Showing 2681-2690 of 5618 results for "".
- National Psoriasis Foundation Awards ZORYVE Seal of Recognitionhttps://reachmd.com/news/national-psoriasis-foundation-awards-zoryve-seal-of-recognition/2474950/The National Psoriasis Foundation (NPF) awarded its first Seal of Recognition to ZORYVE® (roflumilast) cream and foam 0.3%, according to a press release from the Foundation. The NPF Seal of Recognition, according to the org
- Navigating Regulatory Pathways in Gene Therapies for Ocular Disordershttps://reachmd.com/news/navigating-regulatory-pathways-in-gene-therapies-for-ocular-disorders/2474747/Gene therapies are rapidly redefining treatment paradigms for hereditary ocular disorders, yet delivering these advances to patients hinges on navigating complex regulatory pathways. For practicing ophthalmologists confronting conditio
- Precision Frontiers in Nephrology: The Emerging Role of CRISPR and Nanomedicinehttps://reachmd.com/news/transformative-advances-in-gene-editing-and-nanomedicine-for-kidney-diseases/2474618/Recent advancements in gene editing and nanomedicine are reshaping the therapeutic landscape for kidney diseases, offering new avenues for precision treatment and improved patient outcomes. Nephrologists routinely confront the
- Nanoparticle-Mediated TP53 Restoration: A New Frontier in Ovarian Cancer Therapyhttps://reachmd.com/news/restoration-of-tp53-and-nanoparticle-strategy-in-ovarian-cancer-therapy/2474452/A promising leap forward in ovarian cancer treatment has emerged through the use of nanoparticle-based gene therapy aimed at restoring the tumor suppressor gene TP53. Research
- Navigation-Assisted Total Hip Arthroplasty: Assessing the Impact of Obesity on Functional Outcomeshttps://reachmd.com/news/navigation-assisted-total-hip-arthroplasty-assessing-the-impact-of-obesity-on-functional-outcomes/2474366/In the evolving landscape of orthopedic surgery, the intersection of obesity and technology has emerged as a pressing clinical challenge. As total hip arthroplasty (THA) increasingly relies on navigation-assisted systems to enhance precision, surgeons are grappling
- Gold Nanoparticles Show Promise in Restoring Vision Lost to Retinal Degenerationhttps://reachmd.com/news/gold-nanoparticles-show-promise-in-restoring-vision-lost-to-retinal-degeneration/2474192/In a groundbreaking preclinical study, researchers from Brown University have demonstrated a novel technique that may one day help restore vision in individuals with retinal degenerative diseases. By harnessing the unique properties of gold nanoparticles, the team
- Preventing Heart Failure with Preserved Ejection Fraction: Exploring Natural Cardiac Protectionhttps://reachmd.com/news/preventing-heart-failure-with-preserved-ejection-fraction-exploring-natural-cardiac-protection/2474177/Recent research highlights a natural cardiac mechanism that may protect against the onset and progression of heart failure with preserved ejection fraction (HFpEF), emphasizing the potential for early intervention strategies in clinical practice. <
- Global Experts Urge Return to ‘Natural Breast Beauty’ Amid Rise in Aesthetic Complicationshttps://reachmd.com/news/global-experts-urge-return-to-natural-breast-beauty-amid-rise-in-aesthetic-complications/2475346/In response to rising rates of revision surgery and dissatisfaction with overly augmented results, an international coalition of leading plastic surgeons has introduced new framework for achieving more natural outcomes in breast augmentation. The Global Consensus on Natural Breast Beauty,
- Revolutionizing Dermatology: How AI is Transforming Skin, Hair, and Nail Treatmentshttps://reachmd.com/news/revolutionizing-dermatology-how-ai-is-transforming-skin-hair-and-nail-treatments/2471802/Artificial intelligence is dramatically transforming dermatology by introducing advanced diagnostic tools and innovative treatment methods for skin, hair, and nail disorders, ultimately enhancing personalized care. Understanding the Integration
- Revolutionizing Nasal Polyps Management with Monoclonal Antibodieshttps://reachmd.com/news/revolutionizing-nasal-polyps-management-with-monoclonal-antibodies/2471725/Chronic rhinosinusitis with nasal polyps continues to present management challenges. Breakthrough findings from phase 3 clinical trials on monoclonal antibodies offer a promising path forward, moving beyond the limited long-term efficacy of traditional approaches.